Results 31 to 40 of about 21,211 (247)

Improving Cardiovascular Outcomes: The Era of Personalized Therapy in Atherosclerosis

open access: yes, 2022
Data from the European Society of Cardiology report that cardiovascular disease (CVD) is responsible for app [...
Kabłak-Ziembicka, Anna   +1 more
core   +1 more source

Precision Medicine and the future of Cardiovascular Diseases: A Clinically Oriented Comprehensive Review [PDF]

open access: yes, 2023
Cardiac diseases form the lion’s share of the global disease burden, owing to the paradigm shift to non-infectious diseases from infectious ones. The prevalence of CVDs has nearly doubled, increasing from 271 million in 1990 to 523 million in 2019.
Chopra, Hitesh   +17 more
core   +1 more source

Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine

open access: yesJACC: Basic to Translational Science, 2017
Summary: The traditional paradigm of cardiovascular disease research derives insight from large-scale, broadly inclusive clinical studies of well-characterized pathologies.
Kipp W. Johnson, BS   +7 more
doaj   +1 more source

Artificial intelligence in cardiology: Hope for the future and power for the present

open access: yes, 2022
Cardiovascular disease (CVD) is the principal cause of mortality and morbidity globally. With the pressures for improved care and translation of the latest medical advances and knowledge to an actionable plan, clinical decision-making for cardiologists ...
Karatzia, Loucia   +5 more
core   +1 more source

Cardiogenic Shock

open access: yesMajalah Kardiologi Indonesia
In “Cardiogenic Shock” (Indonesian Journal of Cardiology, 43(2), 90-9. https://doi.org/10.30701/ijc.1505), there are an errors noted. An error has been found in the PDF version of this article. The DOI printed in the PDF is incorrect. The correct DOI
H. P. Bagaswoto   +5 more
doaj   +1 more source

European cardiovascular magnetic resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries [PDF]

open access: yes, 2013
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
Monney, P.   +84 more
core   +1 more source

Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction

open access: yesBMC Cardiovascular Disorders, 2023
Background Fibroblast growth factor-23 (FGF23) has been associated to left ventricular (LV) hypertrophy and heart failure (HF) severity. We aimed to investigate the clinical correlates and prognostic value of intact FGF23 (iFGF23) in HF patients. Methods
Giuseppe Vergaro   +10 more
doaj   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho   +7 more
wiley   +1 more source

European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology [position paper]. [PDF]

open access: yes, 2022
AIMS To develop a set of quality indicators (QIs) for the evaluation of the care and outcomes for atherosclerotic cardiovascular disease (ASCVD) prevention.
Arbelo, Elena,   +50 more
core   +1 more source

Intraventricular synchronism assessment by gated-SPECT myocardial perfusion imaging in cardiac resynchronization therapy. Does cardiomyopathy type influence results?

open access: yesEJNMMI Research, 2020
Purpose To analyze the evolution post-cardiac resynchronization therapy (CRT) in left ventricular non-compaction (LVNC) cardiomyopathy (CM) patients compared to other types of CM, according to clinical and functional variables, by using gated-SPECT ...
Amalia Peix   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy